Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
ESRRA modulation by empagliflozin mitigates diabetic tubular injury via mitochondrial restoration (2024-07-24)
-
Early inhibition of the ATM/p53 pathway reduces the susceptibility to atrial fibrillation and atrial remodeling following acute myocardial infarction (2024-07-26)
Journal: CELLULAR SIGNALLING (2024) IF: 4.4Products Cited: HL-1 Cells Line -
The MEF2A/SNHG16/miR-425-5p/NOTCH2 axis induces gemcitabine resistance by inhibiting ferroptosis in the starving bladder tumor microenvironment (2024-08-08)
Journal: CELLULAR SIGNALLING (2024) IF: 4.4Products Cited: Fetal Bovine Serum -
TRPC6 regulates necroptosis in myocardial ischemia/reperfusion injury via Ca2+/CaMKII signaling pathway (2024-08-10)
-
METTL3 -mediated m6A modification of circ_0000620 regulates cisplatin sensitivity and apoptosis in lung adenocarcinoma via the MiR-216b-5p/KRAS axis (2024-08-15)
Journal: CELLULAR SIGNALLING (2024) IF: 4.4Products Cited: Fetal Bovine Serum, RPMI-1640 Medium -
MTFR2 accelerates hepatocellular carcinoma mediated by metabolic reprogramming via the Akt signaling pathway (2024-08-23)
-
Human placental mesenchymal stromal cells alleviate intestinal oxidative damage in mice with graft-versus-host disease via CD73/adenosine/PI3K/Akt/GSK-3β axis (2024-08-28)
Journal: CELLULAR SIGNALLING (2024) IF: 4.4 -
SOX13-mediated transcription of LRP11 enhances malignant properties of tumor cells and CD8+ T cell inactivation in breast cancer through the β-catenin/PD-L1 axis (2024-09-05)
-
MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1/PI3K signaling pathway (2024-09-14)
Journal: CELLULAR SIGNALLING (2024) IF: 4.4Products Cited: DMEM (High glucose) Medium -
Activated PARP1/FAK/COL5A1 signaling facilitates the tumorigenesis of cholesterol-resistant ovarian cancer cells through promoting EMT (2024-09-16)
Journal: CELLULAR SIGNALLING (2024) IF: 4.4Products Cited: Human Ovarian Fibroblast Cells
